Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato-O, O′)-diammine Platinum (II) (NSC 375101D)-Reference-Cited by-同舟云学术

Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato-O, O′)-diammine Platinum (II) (NSC 375101D)

Published:1990-02 Issue:2 Volume:81 Page:196-200
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Sasaki Yasutsuna,Fukuda Masaaki,Morita Masashige,Shinkai Tetsu,Eguchi Kenji,Tamura Tomohide,Ohe Yuichiro,Yamada Kohzo,Kojima Akira,Nakagawa Kazuhiko,Ohmori Toru,Saijo Nagahiro

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1990.tb02548.x/fullpdf

Reference12 articles.

1. A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion;Bishop;Cancer Chemother. Pharmacol.,1989

2. Pharmacokinetics and dosage reduction of cis-diammine-(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function;Egorin;Cancer Res.,1984

3. Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum (II) analog diamminecyclo-butanedicarboxylatoplatinum;Egorin;Cancer Res.,1985

4. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and the correlation with clinical toxicities;Egorin;Cancer Res.,1986

5. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction;Egorin;Cancer Res.,1987

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer;The Oncologist;2018-10-25

2. Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer;Cancer Chemotherapy and Pharmacology;2015-06-07

3. Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer;Annals of Surgical Oncology;2015-02-18

4. A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI);Esophagus;2014-03-12

5. Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer;Cancer Chemotherapy and Pharmacology;2013-01-10